Astonea Labs Ltd.
Industry:
Pharmaceuticals & Drugs
Issue Details
Open Date
27 May 2025Close Date
29 May 2025Size (in Crs.)
25.60 - 27.00
Size (Shares)
-Listing On
BSE
Issue Terms
Price Range
-7Lot Size
1000
Type
Book building
Face Value
10
Market Lot
1
Objective of the Issue
1) Funding of expenses proposed to be incurred towards Product registration in Bolivia, SouthAmerica;2) Purchase and installation of plant and machineries for ointment production for the purpose ofexport in accordance with the international standards and protocols, on the 2nd floor of theExisting Premises (factory at Haripur, Tehsil - Raipur Rani, District Panchkula, Haryana to bereferred to as the “Existing Premises”);3) Advertising, marketing and brand building;4) Investment in procuring hardware and software;5) Funding of working capital requirements; and6) General corporate purposes
Description
Our Company specializes in the manufacturing and marketing of a wide range of pharmaceutical andcosmetic products. These include antibiotic drugs, anti-cold medications, antihistamines, and drugs fordiabetes, cardiovascular diseases, gynecological concerns, analgesics, fungal infections, andmultivitamins. We also offer products for skin, tooth, and hair care, available in various forms such asgels, ointments, creams, lotions, oils, and serums. All our products adhere to the rigorous standards ofthe pharmaceuti... Show More
Address
Sco 186-187, 2nd Floor , Cabin No. 206, Sector 8 C , Sector 8
Chandigarh
160009
Promoter Holding
Promoters:
Ashish Gulati
Total Share Capital
7599970
Offered to Public
2790000
% Promoter's Holding (Pre-Issue)
98.42
% Promoter's Holding (Post-Issue)
-
Shares on offer
Total Share Offer
7599970
Of above offred to public
2790000
Post Issue shares
NA
Post Issue Promoters
-
Lead Managers to the Issue:
Oneview Corporate Advisors Pvt Ltd.
Registrar Details
Registrar Name:
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Address
Karvy Selenium Tower B, Plot 31-32 , Gachibowli,Financial District , Nanakramguda , Hyderabad
500032